These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 6136457)

  • 1. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncatecholaminergic treatments of tardive dyskinesia.
    Alphs L; Davis JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):380-5. PubMed ID: 6129267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The behavioral toxicity of bromocriptine in patients with psychiatric illness.
    Perovich RM; Lieberman JA; Fleischhacker WW; Alvir J
    J Clin Psychopharmacol; 1989 Dec; 9(6):417-22. PubMed ID: 2574194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing tardive dyskinesia.
    Casey DE
    J Clin Psychiatry; 1978 Oct; 39(10):748-53. PubMed ID: 30759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate in tardive dyskinesia.
    Casey DE; Hammerstad JP
    J Clin Psychiatry; 1979 Nov; 40(11):483-5. PubMed ID: 385585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatments of tardive dyskinesia in the 1980s.
    Jeste DV; Lohr JB; Clark K; Wyatt RJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
    Bourgeois M
    Encephale; 1977; 3(4):299-320. PubMed ID: 611013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Ringwald E
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):294-8. PubMed ID: 33397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two cases of tardive Tourette syndrome].
    Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of tardive dyskinesia caused by neuroleptics].
    Piccinin GL; Piccirilli M; Rizzo PA
    Riv Neurol; 1984; 54(3):199-215. PubMed ID: 6147888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia.
    Goetz CG; Klawans HL
    Neurol Clin; 1984 Aug; 2(3):605-14. PubMed ID: 6152483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.